Base de données de recherche subventionnée canadienne sur la COVID-19

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 631 through 640 of 882 results (Download Results)

Show results per page

Rapid Prototyping and Deployment of a Therapeutic Pan-Coronavirus Fusogenix DNA Vaccine Engineered to Eliminate ADE

Lewis, John D | University of Alberta | Operating Grant | $4,225,000

CIHR Alberta 2020

Rapid RNA sequencing of coronavirus for public health surveillance and transmission

Croxen, Matthew A | University of Alberta | Operating Grant | $788,040

CIHR Alberta 2020

The role of interleukin-10 responsiveness in lung inflammation in SARS CoV2 infection

Mui, Alice L | University of British Columbia | Operating Grant | $150,072

CIHR British Columbia 2020

SARS-CoV-2 immunization strategies to enhance protective immunity with reduced risk of antibody-dependent enhancement (ADE)

Archambault, Denis | Université du Québec à Montréal | Operating Grant | $622,782

CIHR Quebec 2020

Contribution of genetic variation of ACE2, the receptor for SARS-CoV-2, to COVID‑19 disease expression and development of therapeutics

Haas, Kurt | University of British Columbia | Operating Grant | $172,414

CIHR British Columbia 2020

Inferring undiagnosed sources of COVID‑19 infections using viral genomes

Long, Quan | The University of Calgary | Operating Grant | $99,000

CIHR Alberta 2020

Supporting children and adolescents’ mental health in the context of pandemic and confinement: A scoping review of interventions and ethical challenges

Montreuil, Marjorie | McGill University | Operating Grant | $49,628

CIHR Quebec 2020

COVID-19’s differential impact on the mental and emotional health of Indigenous Peoples and Newcomers: A socioeconomic analysis of Canada, US and Mexico

Wilkinson, Lori A | University of Manitoba | Operating Grant | $671,332

CIHR Manitoba 2020

Identification of Factors to Improve Effectiveness and Implementation of a Multi-faceted COVID‑19 Mental Health Intervention: Follow-up to the SPIN-CHAT Trial

Thombs, Brett D | Lady Davis Institute for Medical Research | Operating Grant | $89,901

CIHR Quebec 2020

Development of vaccine candidates and monoclonal antibodies to interrupt the spread of the novel coronavirus, COVID-19.

Kozak, Robert A | University of Toronto | Operating Grant | $999,356

CIHR Ontario 2020

Base de données de recherche subventionnée canadienne sur la COVID-19

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

Rapid Prototyping and Deployment of a Therapeutic Pan-Coronavirus Fusogenix DNA Vaccine Engineered to Eliminate ADE

Rapid RNA sequencing of coronavirus for public health surveillance and transmission

The role of interleukin-10 responsiveness in lung inflammation in SARS CoV2 infection

SARS-CoV-2 immunization strategies to enhance protective immunity with reduced risk of antibody-dependent enhancement (ADE)

Contribution of genetic variation of ACE2, the receptor for SARS-CoV-2, to COVID‑19 disease expression and development of therapeutics

Inferring undiagnosed sources of COVID‑19 infections using viral genomes

Supporting children and adolescents’ mental health in the context of pandemic and confinement: A scoping review of interventions and ethical challenges

COVID-19’s differential impact on the mental and emotional health of Indigenous Peoples and Newcomers: A socioeconomic analysis of Canada, US and Mexico

Identification of Factors to Improve Effectiveness and Implementation of a Multi-faceted COVID‑19 Mental Health Intervention: Follow-up to the SPIN-CHAT Trial

Development of vaccine candidates and monoclonal antibodies to interrupt the spread of the novel coronavirus, COVID-19.